A joint venture has sold a majority interest in a Parsippany office building, following upgrades at the property that helped lure a pharmaceutical company’s U.S. headquarters in 2018.
The buyer of a two-building, 550,000-square-foot office complex in Parsippany has secured nearly $60 million in financing, under a newly announced transaction by JLL.
An investment group has acquired a two-building, 550,000-square-foot office complex in Parsippany, adding to its footprint after having revitalized an adjacent property.
NAIOP New Jersey has announced the finalists for its coveted Deal of the Year awards, highlighting six of the state’s most impactful projects and transactions of 2018.
Teva Pharmaceuticals isn’t the only life sciences company to impact New Jersey’s office market this year, as several others have inked sizable leases to expand or upgrade their space.
P3 Properties has made another addition to its New Jersey office portfolio, acquiring a 233,000-square-foot building in Bedminster that is home to a major pharmaceutical company.
